Elsevier MDL to build new Electronic Lab Notebook for life sciences research

In response to industry and customer demand, Elsevier MDL has launched a

dedicated, phased program to build a robust, scalable, enterprise-strength

electronic laboratory notebook (ELN) for the life sciences, built on MDL

Isentris technology, for delivery in 2006.

'Elsevier MDL pioneered the first all-electronic laboratory notebook over a

decade ago and is today a leader in the development and deployment of advanced

ELN systems that combine the best features of paper notebooks with robust

electronic data handling capabilities,' said Elsevier MDL CEO Lars Barfod. 'A

new generation ELN that satisfies both intellectual property and regulatory

requirements is a unifying application that will significantly reduce cycle time

in biopharmaceutical R&D.'

Biopharma researchers engaged in experiment planning and data

capture/analysis supporting parallel synthesis, single- and multi-step reactions

and other complex processes are increasingly demanding an electronic laboratory

data capture, report generation, auditing, tracking and storage solution that

supports FDA- and OSHA-mandated Good Manufacturing and Good Laboratory

Practices, as well as 21 CFR Part 11 compliance.

An integrated ELN system offers many productivity benefits: streamlining

workflows, automating repetitive tasks, documenting discovery history for patent

disclosure and defense and leveraging past work. In addition, an integrated ELN

ensures that information captured in the system can benefit everyone in an

R&D



organization.

DQC NEWS BUREAU